Elevance Health Inc. (0HG8.L)
USD 371.42
(0.32%)
USD 371.42
(0.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 69.52 Billion USD | 4.74% |
| 2022 | 66.37 Billion USD | 8.5% |
| 2021 | 61.17 Billion USD | 14.53% |
| 2020 | 53.41 Billion USD | 16.82% |
| 2019 | 45.72 Billion USD | 6.26% |
| 2018 | 43.03 Billion USD | -2.29% |
| 2017 | 44.03 Billion USD | 10.14% |
| 2016 | 39.98 Billion USD | 3.38% |
| 2015 | 38.67 Billion USD | 2.27% |
| 2014 | 37.81 Billion USD | 8.63% |
| 2013 | 34.8 Billion USD | -0.98% |
| 2012 | 35.15 Billion USD | 22.35% |
| 2011 | 28.73 Billion USD | 9.02% |
| 2010 | 26.35 Billion USD | -3.33% |
| 2009 | 27.26 Billion USD | 1.08% |
| 2008 | 26.97 Billion USD | -7.22% |
| 2007 | 29.06 Billion USD | 6.94% |
| 2006 | 27.18 Billion USD | 2.92% |
| 2005 | 26.41 Billion USD | 30.24% |
| 2004 | 20.27 Billion USD | 172.62% |
| 2003 | 7.43 Billion USD | 7.33% |
| 2002 | 6.93 Billion USD | 64.37% |
| 2001 | 4.21 Billion USD | 605.71% |
| 2000 | 597.5 Million USD | 14.46% |
| 1999 | 522 Million USD | 72.9% |
| 1998 | 301.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 72.65 Billion USD | 2.78% |
| 2024 Q1 | 71.18 Billion USD | 2.39% |
| 2024 Q2 | 70.69 Billion USD | -0.69% |
| 2023 FY | 69.52 Billion USD | 4.74% |
| 2023 Q3 | 71.93 Billion USD | 1.53% |
| 2023 Q4 | 69.52 Billion USD | -3.36% |
| 2023 Q1 | 71.58 Billion USD | 7.84% |
| 2023 Q2 | 70.85 Billion USD | -1.01% |
| 2022 Q2 | 65.01 Billion USD | 0.86% |
| 2022 Q4 | 66.37 Billion USD | -0.9% |
| 2022 FY | 66.37 Billion USD | 8.5% |
| 2022 Q1 | 64.45 Billion USD | 5.35% |
| 2022 Q3 | 66.98 Billion USD | 3.03% |
| 2021 Q2 | 61.05 Billion USD | -1.16% |
| 2021 FY | 61.17 Billion USD | 14.53% |
| 2021 Q3 | 62.25 Billion USD | 1.97% |
| 2021 Q4 | 61.17 Billion USD | -1.72% |
| 2021 Q1 | 61.76 Billion USD | 15.63% |
| 2020 Q1 | 50.7 Billion USD | 10.89% |
| 2020 FY | 53.41 Billion USD | 16.82% |
| 2020 Q4 | 53.41 Billion USD | 1.45% |
| 2020 Q3 | 52.65 Billion USD | -1.62% |
| 2020 Q2 | 53.52 Billion USD | 5.55% |
| 2019 FY | 45.72 Billion USD | 6.26% |
| 2019 Q3 | 46.47 Billion USD | 3.15% |
| 2019 Q4 | 45.72 Billion USD | -1.62% |
| 2019 Q1 | 44.52 Billion USD | 3.47% |
| 2019 Q2 | 45.05 Billion USD | 1.2% |
| 2018 Q3 | 45.35 Billion USD | -0.64% |
| 2018 FY | 43.03 Billion USD | -2.29% |
| 2018 Q2 | 45.64 Billion USD | -1.39% |
| 2018 Q4 | 43.03 Billion USD | -5.12% |
| 2018 Q1 | 46.28 Billion USD | 5.11% |
| 2017 Q2 | 41.8 Billion USD | -2.44% |
| 2017 FY | 44.03 Billion USD | 10.14% |
| 2017 Q4 | 44.03 Billion USD | 3.96% |
| 2017 Q3 | 42.36 Billion USD | 1.33% |
| 2017 Q1 | 42.85 Billion USD | 7.18% |
| 2016 Q3 | 39.65 Billion USD | -0.44% |
| 2016 FY | 39.98 Billion USD | 3.38% |
| 2016 Q2 | 39.82 Billion USD | -1.2% |
| 2016 Q1 | 40.31 Billion USD | 4.24% |
| 2016 Q4 | 39.98 Billion USD | 0.82% |
| 2015 Q1 | 41.21 Billion USD | 8.99% |
| 2015 Q2 | 41.2 Billion USD | -0.03% |
| 2015 Q3 | 39.09 Billion USD | -5.1% |
| 2015 Q4 | 38.67 Billion USD | -1.09% |
| 2015 FY | 38.67 Billion USD | 2.27% |
| 2014 Q4 | 37.81 Billion USD | 0.13% |
| 2014 Q3 | 37.76 Billion USD | -0.43% |
| 2014 Q1 | 37.34 Billion USD | 7.27% |
| 2014 Q2 | 37.92 Billion USD | 1.57% |
| 2014 FY | 37.81 Billion USD | 8.63% |
| 2013 Q4 | 34.8 Billion USD | -1.82% |
| 2013 FY | 34.8 Billion USD | -0.98% |
| 2013 Q2 | 35.07 Billion USD | -0.03% |
| 2013 Q1 | 35.09 Billion USD | -0.18% |
| 2013 Q3 | 35.45 Billion USD | 1.07% |
| 2012 Q3 | 32 Billion USD | 3.59% |
| 2012 Q1 | 28.96 Billion USD | 0.83% |
| 2012 Q4 | 35.15 Billion USD | 9.85% |
| 2012 FY | 35.15 Billion USD | 22.35% |
| 2012 Q2 | 30.89 Billion USD | 6.64% |
| 2011 FY | 28.73 Billion USD | 9.02% |
| 2011 Q4 | 28.73 Billion USD | -0.35% |
| 2011 Q1 | 26.93 Billion USD | 2.22% |
| 2011 Q2 | 26.69 Billion USD | -0.91% |
| 2011 Q3 | 28.83 Billion USD | 8.0% |
| 2010 Q1 | 26.66 Billion USD | -2.2% |
| 2010 FY | 26.35 Billion USD | -3.33% |
| 2010 Q2 | 26.36 Billion USD | -1.1% |
| 2010 Q4 | 26.35 Billion USD | -1.19% |
| 2010 Q3 | 26.67 Billion USD | 1.14% |
| 2009 Q2 | 27.09 Billion USD | -2.92% |
| 2009 Q3 | 26.63 Billion USD | -1.7% |
| 2009 Q4 | 27.26 Billion USD | 2.37% |
| 2009 FY | 27.26 Billion USD | 1.08% |
| 2009 Q1 | 27.9 Billion USD | 3.47% |
| 2008 Q4 | 26.97 Billion USD | -3.97% |
| 2008 Q1 | 30.05 Billion USD | 3.38% |
| 2008 Q2 | 29.72 Billion USD | -1.1% |
| 2008 FY | 26.97 Billion USD | -7.22% |
| 2008 Q3 | 28.08 Billion USD | -5.5% |
| 2007 Q3 | 29.22 Billion USD | 0.07% |
| 2007 Q4 | 29.06 Billion USD | -0.53% |
| 2007 FY | 29.06 Billion USD | 6.94% |
| 2007 Q2 | 29.2 Billion USD | 3.02% |
| 2007 Q1 | 28.34 Billion USD | 4.29% |
| 2006 Q3 | 27.34 Billion USD | 1.81% |
| 2006 FY | 27.18 Billion USD | 2.92% |
| 2006 Q4 | 27.18 Billion USD | -0.57% |
| 2006 Q2 | 26.85 Billion USD | -1.46% |
| 2006 Q1 | 27.25 Billion USD | 3.18% |
| 2005 Q1 | 20.48 Billion USD | 1.02% |
| 2005 Q2 | 21.13 Billion USD | 3.18% |
| 2005 Q3 | 20.62 Billion USD | -2.45% |
| 2005 FY | 26.41 Billion USD | 30.24% |
| 2005 Q4 | 26.41 Billion USD | 28.08% |
| 2004 Q4 | 20.27 Billion USD | 176.44% |
| 2004 Q3 | 7.33 Billion USD | 3.39% |
| 2004 Q2 | 7.09 Billion USD | -6.32% |
| 2004 FY | 20.27 Billion USD | 172.62% |
| 2004 Q1 | 7.57 Billion USD | 1.82% |
| 2003 Q2 | 7.17 Billion USD | 2.04% |
| 2003 Q3 | 7.35 Billion USD | 2.48% |
| 2003 Q4 | 7.43 Billion USD | 1.18% |
| 2003 FY | 7.43 Billion USD | 7.33% |
| 2003 Q1 | 7.03 Billion USD | 1.44% |
| 2002 Q3 | 6.9 Billion USD | 56.66% |
| 2002 FY | 6.93 Billion USD | 64.37% |
| 2002 Q4 | 6.93 Billion USD | 0.3% |
| 2002 Q1 | 4.27 Billion USD | 1.43% |
| 2002 Q2 | 4.41 Billion USD | 3.13% |
| 2001 FY | 4.21 Billion USD | 605.71% |
| 2001 Q4 | 4.21 Billion USD | 7.61% |
| 2001 Q3 | 3.91 Billion USD | 0.0% |
| 2000 FY | 597.5 Million USD | 14.46% |
| 1999 FY | 522 Million USD | 72.9% |
| 1998 FY | 301.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -58012.107% |
| Accuray Incorporated | 423.54 Million USD | -16314.626% |
| Align Technology, Inc. | 2.45 Billion USD | -2733.755% |
| AxoGen, Inc. | 101.16 Million USD | -68624.422% |
| Boston Scientific Corporation | 15.6 Billion USD | -345.489% |
| CVS Health Corporation | 173.09 Billion USD | 59.835% |
| Cardinal Health, Inc. | 48.33 Billion USD | -43.842% |
| Centene Corporation | 58.68 Billion USD | -18.468% |
| DaVita Inc. | 14.87 Billion USD | -367.346% |
| HCA Healthcare, Inc. | 55.15 Billion USD | -26.059% |
| Hologic, Inc. | 4.02 Billion USD | -1626.85% |
| Humana Inc. | 30.74 Billion USD | -126.113% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -3815.917% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -686.94% |
| Masimo Corporation | 1.67 Billion USD | -4046.419% |
| McKesson Corporation | 69.04 Billion USD | -0.697% |
| Patterson Companies, Inc. | 1.89 Billion USD | -3568.76% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -814.295% |
| ResMed Inc. | 2 Billion USD | -3361.696% |
| Henry Schein, Inc. | 5.42 Billion USD | -1182.712% |
| Teladoc Health, Inc. | 2.06 Billion USD | -3264.62% |
| Universal Health Services, Inc. | 8.15 Billion USD | -752.526% |
| Veeva Systems Inc. | 1.26 Billion USD | -5391.132% |
| Baxter International Inc. | 19.8 Billion USD | -250.984% |
| Becton, Dickinson and Company | 26.98 Billion USD | -157.645% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -3300.988% |
| Danaher Corporation | 30.99 Billion USD | -124.282% |
| Stryker Corporation | 21.31 Billion USD | -226.108% |
| Medtronic plc | 39.56 Billion USD | -75.736% |